HomeCLRB • NASDAQ
Follow
Cellectar Biosciences Inc
Previous close
$3.31
Day range
$3.17 - $3.37
Year range
$1.33 - $4.45
Market cap
103.56M USD
Avg Volume
1.04M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 12.55M | 69.05% |
Net income | -7.45M | -3.24% |
Net profit margin | — | — |
Earnings per share | -0.40 | 27.27% |
EBITDA | -12.48M | -68.98% |
Effective tax rate | 0.80% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.56M | -51.85% |
Total assets | 12.08M | -44.07% |
Total liabilities | 13.43M | 120.83% |
Total equity | -1.36M | — |
Shares outstanding | 32.26M | — |
Price to book | -9.19 | — |
Return on assets | -186.58% | — |
Return on capital | -1,447.91% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -7.45M | -3.24% |
Cash from operations | -9.60M | -29.47% |
Cash from investing | -266.76K | -126.34% |
Cash from financing | 441.00K | -95.41% |
Net change in cash | -9.42M | -552.73% |
Free cash flow | -10.26M | -107.89% |
About
Founded
1996
Headquarters
Website
Employees
20